 | • レポートコード：QFJ1-3874 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、自己調整血漿療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純粋多血小板血漿(P-PRP)、白血球・多血小板血漿(LPRP)、純粋多血小板血漿フィブリン(P-PRF)、白血球・多血小板血漿フィブリン(L-PRF)）、用途別市場規模（病院、専門診療所、外来手術センター、整形外科＆外傷センター、研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・自己調整血漿療法の市場動向 ・企業の競争状況、市場シェア ・自己調整血漿療法の種類別市場規模と予測2016-2027（純粋多血小板血漿(P-PRP)、白血球・多血小板血漿(LPRP)、純粋多血小板血漿フィブリン(P-PRF)、白血球・多血小板血漿フィブリン(L-PRF)） ・自己調整血漿療法の用途別市場規模と予測2016-2027（病院、専門診療所、外来手術センター、整形外科＆外傷センター、研究機関） ・自己調整血漿療法の北米市場規模2016-2027（アメリカ、カナダ） ・自己調整血漿療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・自己調整血漿療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自己調整血漿療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・自己調整血漿療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Zimmer Biomet Inc.、Terumo Corporation、AdiStem Ltd.、Arthrex, Inc.、Stryker Corporation、Cesca Therapeutics, Inc.、Biotechnology Institute BTI、Dr. PRP America LLC、EmCyte Corporation、Vivostat A/S、Regen Lab SA、Royal Biologics、Exactech, Inc.、Plateltex S.R.O.） ・結論 |
Autologous conditioned plasma therapy is used to treat a range of problems, such as musculoskeletal injuries, sports injuries and trauma. Today, among other things, it is widely used to treat skin ulcers, sports injuries, and cosmetic surgery. The growing demand for user-friendly treatment procedures is driving the expansion of the autologous conditioned plasma therapy market.
This procedure provides excellent and effective treatment without the need for painful surgery.
Market Analysis and Insights: Global Autologous Conditioned Plasma Therapy Market
The global Autologous Conditioned Plasma Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autologous Conditioned Plasma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autologous Conditioned Plasma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autologous Conditioned Plasma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autologous Conditioned Plasma Therapy market.
Global Autologous Conditioned Plasma Therapy Scope and Market Size
Autologous Conditioned Plasma Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autologous Conditioned Plasma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte- and Platelet-Rich Plasma (LPRP)
Pure Platelet-Rich Fibrin (P-PRF)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Segment by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Orthopedic & Trauma Centers
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Zimmer Biomet Inc.
Terumo Corporation
AdiStem Ltd.
Arthrex, Inc.
Stryker Corporation
Cesca Therapeutics, Inc.
Biotechnology Institute BTI
Dr. PRP America LLC
EmCyte Corporation
Vivostat A/S
Regen Lab SA
Royal Biologics
Exactech, Inc.
Plateltex S.R.O.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Conditioned Plasma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pure Platelet-Rich Plasma (P-PRP)
1.2.3 Leukocyte- and Platelet-Rich Plasma (LPRP)
1.2.4 Pure Platelet-Rich Fibrin (P-PRF)
1.2.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Autologous Conditioned Plasma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Orthopedic & Trauma Centers
1.3.6 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autologous Conditioned Plasma Therapy Market Perspective (2016-2027)
2.2 Autologous Conditioned Plasma Therapy Growth Trends by Regions
2.2.1 Autologous Conditioned Plasma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autologous Conditioned Plasma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Autologous Conditioned Plasma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Autologous Conditioned Plasma Therapy Industry Dynamic
2.3.1 Autologous Conditioned Plasma Therapy Market Trends
2.3.2 Autologous Conditioned Plasma Therapy Market Drivers
2.3.3 Autologous Conditioned Plasma Therapy Market Challenges
2.3.4 Autologous Conditioned Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Conditioned Plasma Therapy Players by Revenue
3.1.1 Global Top Autologous Conditioned Plasma Therapy Players by Revenue (2016-2021)
3.1.2 Global Autologous Conditioned Plasma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Autologous Conditioned Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autologous Conditioned Plasma Therapy Revenue
3.4 Global Autologous Conditioned Plasma Therapy Market Concentration Ratio
3.4.1 Global Autologous Conditioned Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Conditioned Plasma Therapy Revenue in 2020
3.5 Autologous Conditioned Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Autologous Conditioned Plasma Therapy Product Solution and Service
3.7 Date of Enter into Autologous Conditioned Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Conditioned Plasma Therapy Breakdown Data by Type
4.1 Global Autologous Conditioned Plasma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Type (2022-2027)
5 Autologous Conditioned Plasma Therapy Breakdown Data by Application
5.1 Global Autologous Conditioned Plasma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Autologous Conditioned Plasma Therapy Market Size (2016-2027)
6.2 North America Autologous Conditioned Plasma Therapy Market Size by Type
6.2.1 North America Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021)
6.2.2 North America Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027)
6.2.3 North America Autologous Conditioned Plasma Therapy Market Size by Type (2016-2027)
6.3 North America Autologous Conditioned Plasma Therapy Market Size by Application
6.3.1 North America Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021)
6.3.2 North America Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027)
6.3.3 North America Autologous Conditioned Plasma Therapy Market Size by Application (2016-2027)
6.4 North America Autologous Conditioned Plasma Therapy Market Size by Country
6.4.1 North America Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021)
6.4.2 North America Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Autologous Conditioned Plasma Therapy Market Size (2016-2027)
7.2 Europe Autologous Conditioned Plasma Therapy Market Size by Type
7.2.1 Europe Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Autologous Conditioned Plasma Therapy Market Size by Type (2016-2027)
7.3 Europe Autologous Conditioned Plasma Therapy Market Size by Application
7.3.1 Europe Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Autologous Conditioned Plasma Therapy Market Size by Application (2016-2027)
7.4 Europe Autologous Conditioned Plasma Therapy Market Size by Country
7.4.1 Europe Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type
8.2.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application
8.3.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region
8.4.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autologous Conditioned Plasma Therapy Market Size (2016-2027)
9.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Type
9.2.1 Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2016-2027)
9.3 Latin America Autologous Conditioned Plasma Therapy Market Size by Application
9.3.1 Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2016-2027)
9.4 Latin America Autologous Conditioned Plasma Therapy Market Size by Country
9.4.1 Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type
10.2.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application
10.3.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country
10.4.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zimmer Biomet Inc.
11.1.1 Zimmer Biomet Inc. Company Details
11.1.2 Zimmer Biomet Inc. Business Overview
11.1.3 Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Introduction
11.1.4 Zimmer Biomet Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.1.5 Zimmer Biomet Inc. Recent Development
11.2 Terumo Corporation
11.2.1 Terumo Corporation Company Details
11.2.2 Terumo Corporation Business Overview
11.2.3 Terumo Corporation Autologous Conditioned Plasma Therapy Introduction
11.2.4 Terumo Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.2.5 Terumo Corporation Recent Development
11.3 AdiStem Ltd.
11.3.1 AdiStem Ltd. Company Details
11.3.2 AdiStem Ltd. Business Overview
11.3.3 AdiStem Ltd. Autologous Conditioned Plasma Therapy Introduction
11.3.4 AdiStem Ltd. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.3.5 AdiStem Ltd. Recent Development
11.4 Arthrex, Inc.
11.4.1 Arthrex, Inc. Company Details
11.4.2 Arthrex, Inc. Business Overview
11.4.3 Arthrex, Inc. Autologous Conditioned Plasma Therapy Introduction
11.4.4 Arthrex, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.4.5 Arthrex, Inc. Recent Development
11.5 Stryker Corporation
11.5.1 Stryker Corporation Company Details
11.5.2 Stryker Corporation Business Overview
11.5.3 Stryker Corporation Autologous Conditioned Plasma Therapy Introduction
11.5.4 Stryker Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.5.5 Stryker Corporation Recent Development
11.6 Cesca Therapeutics, Inc.
11.6.1 Cesca Therapeutics, Inc. Company Details
11.6.2 Cesca Therapeutics, Inc. Business Overview
11.6.3 Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Introduction
11.6.4 Cesca Therapeutics, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.6.5 Cesca Therapeutics, Inc. Recent Development
11.7 Biotechnology Institute BTI
11.7.1 Biotechnology Institute BTI Company Details
11.7.2 Biotechnology Institute BTI Business Overview
11.7.3 Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Introduction
11.7.4 Biotechnology Institute BTI Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.7.5 Biotechnology Institute BTI Recent Development
11.8 Dr. PRP America LLC
11.8.1 Dr. PRP America LLC Company Details
11.8.2 Dr. PRP America LLC Business Overview
11.8.3 Dr. PRP America LLC Autologous Conditioned Plasma Therapy Introduction
11.8.4 Dr. PRP America LLC Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.8.5 Dr. PRP America LLC Recent Development
11.9 EmCyte Corporation
11.9.1 EmCyte Corporation Company Details
11.9.2 EmCyte Corporation Business Overview
11.9.3 EmCyte Corporation Autologous Conditioned Plasma Therapy Introduction
11.9.4 EmCyte Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.9.5 EmCyte Corporation Recent Development
11.10 Vivostat A/S
11.10.1 Vivostat A/S Company Details
11.10.2 Vivostat A/S Business Overview
11.10.3 Vivostat A/S Autologous Conditioned Plasma Therapy Introduction
11.10.4 Vivostat A/S Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.10.5 Vivostat A/S Recent Development
11.11 Regen Lab SA
11.11.1 Regen Lab SA Company Details
11.11.2 Regen Lab SA Business Overview
11.11.3 Regen Lab SA Autologous Conditioned Plasma Therapy Introduction
11.11.4 Regen Lab SA Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.11.5 Regen Lab SA Recent Development
11.12 Royal Biologics
11.12.1 Royal Biologics Company Details
11.12.2 Royal Biologics Business Overview
11.12.3 Royal Biologics Autologous Conditioned Plasma Therapy Introduction
11.12.4 Royal Biologics Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.12.5 Royal Biologics Recent Development
11.13 Exactech, Inc.
11.13.1 Exactech, Inc. Company Details
11.13.2 Exactech, Inc. Business Overview
11.13.3 Exactech, Inc. Autologous Conditioned Plasma Therapy Introduction
11.13.4 Exactech, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.13.5 Exactech, Inc. Recent Development
11.14 Plateltex S.R.O.
11.14.1 Plateltex S.R.O. Company Details
11.14.2 Plateltex S.R.O. Business Overview
11.14.3 Plateltex S.R.O. Autologous Conditioned Plasma Therapy Introduction
11.14.4 Plateltex S.R.O. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021)
11.14.5 Plateltex S.R.O. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Autologous Conditioned Plasma Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pure Platelet-Rich Plasma (P-PRP)
Table 3. Key Players of Leukocyte- and Platelet-Rich Plasma (LPRP)
Table 4. Key Players of Pure Platelet-Rich Fibrin (P-PRF)
Table 5. Key Players of Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Table 6. Global Autologous Conditioned Plasma Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Autologous Conditioned Plasma Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Autologous Conditioned Plasma Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Autologous Conditioned Plasma Therapy Market Share by Regions (2016-2021)
Table 10. Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Autologous Conditioned Plasma Therapy Market Share by Regions (2022-2027)
Table 12. Autologous Conditioned Plasma Therapy Market Trends
Table 13. Autologous Conditioned Plasma Therapy Market Drivers
Table 14. Autologous Conditioned Plasma Therapy Market Challenges
Table 15. Autologous Conditioned Plasma Therapy Market Restraints
Table 16. Global Autologous Conditioned Plasma Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Autologous Conditioned Plasma Therapy Market Share by Players (2016-2021)
Table 18. Global Top Autologous Conditioned Plasma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Conditioned Plasma Therapy as of 2020)
Table 19. Ranking of Global Top Autologous Conditioned Plasma Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Autologous Conditioned Plasma Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Autologous Conditioned Plasma Therapy Product Solution and Service
Table 23. Date of Enter into Autologous Conditioned Plasma Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Autologous Conditioned Plasma Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Zimmer Biomet Inc. Company Details
Table 64. Zimmer Biomet Inc. Business Overview
Table 65. Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Product
Table 66. Zimmer Biomet Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 67. Zimmer Biomet Inc. Recent Development
Table 68. Terumo Corporation Company Details
Table 69. Terumo Corporation Business Overview
Table 70. Terumo Corporation Autologous Conditioned Plasma Therapy Product
Table 71. Terumo Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 72. Terumo Corporation Recent Development
Table 73. AdiStem Ltd. Company Details
Table 74. AdiStem Ltd. Business Overview
Table 75. AdiStem Ltd. Autologous Conditioned Plasma Therapy Product
Table 76. AdiStem Ltd. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 77. AdiStem Ltd. Recent Development
Table 78. Arthrex, Inc. Company Details
Table 79. Arthrex, Inc. Business Overview
Table 80. Arthrex, Inc. Autologous Conditioned Plasma Therapy Product
Table 81. Arthrex, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 82. Arthrex, Inc. Recent Development
Table 83. Stryker Corporation Company Details
Table 84. Stryker Corporation Business Overview
Table 85. Stryker Corporation Autologous Conditioned Plasma Therapy Product
Table 86. Stryker Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 87. Stryker Corporation Recent Development
Table 88. Cesca Therapeutics, Inc. Company Details
Table 89. Cesca Therapeutics, Inc. Business Overview
Table 90. Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Product
Table 91. Cesca Therapeutics, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 92. Cesca Therapeutics, Inc. Recent Development
Table 93. Biotechnology Institute BTI Company Details
Table 94. Biotechnology Institute BTI Business Overview
Table 95. Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Product
Table 96. Biotechnology Institute BTI Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 97. Biotechnology Institute BTI Recent Development
Table 98. Dr. PRP America LLC Company Details
Table 99. Dr. PRP America LLC Business Overview
Table 100. Dr. PRP America LLC Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 101. Dr. PRP America LLC Recent Development
Table 102. EmCyte Corporation Company Details
Table 103. EmCyte Corporation Business Overview
Table 104. EmCyte Corporation Autologous Conditioned Plasma Therapy Product
Table 105. EmCyte Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 106. EmCyte Corporation Recent Development
Table 107. Vivostat A/S Company Details
Table 108. Vivostat A/S Business Overview
Table 109. Vivostat A/S Autologous Conditioned Plasma Therapy Product
Table 110. Vivostat A/S Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 111. Vivostat A/S Recent Development
Table 112. Regen Lab SA Company Details
Table 113. Regen Lab SA Business Overview
Table 114. Regen Lab SA Autologous Conditioned Plasma Therapy Product
Table 115. Regen Lab SA Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 116. Regen Lab SA Recent Development
Table 117. Royal Biologics Company Details
Table 118. Royal Biologics Business Overview
Table 119. Royal Biologics Autologous Conditioned Plasma Therapy Product
Table 120. Royal Biologics Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 121. Royal Biologics Recent Development
Table 122. Exactech, Inc. Company Details
Table 123. Exactech, Inc. Business Overview
Table 124. Exactech, Inc. Autologous Conditioned Plasma Therapy Product
Table 125. Exactech, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 126. Exactech, Inc. Recent Development
Table 127. Plateltex S.R.O. Company Details
Table 128. Plateltex S.R.O. Business Overview
Table 129. Plateltex S.R.O. Autologous Conditioned Plasma Therapy Product
Table 130. Plateltex S.R.O. Revenue in Autologous Conditioned Plasma Therapy Business (2016-2021) & (US$ Million)
Table 131. Plateltex S.R.O. Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Conditioned Plasma Therapy Market Share by Type: 2020 VS 2027
Figure 2. Pure Platelet-Rich Plasma (P-PRP) Features
Figure 3. Leukocyte- and Platelet-Rich Plasma (LPRP) Features
Figure 4. Pure Platelet-Rich Fibrin (P-PRF) Features
Figure 5. Leukocyte- and Platelet-Rich Fibrin (L-PRF) Features
Figure 6. Global Autologous Conditioned Plasma Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Specialized Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Orthopedic & Trauma Centers Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Autologous Conditioned Plasma Therapy Report Years Considered
Figure 13. Global Autologous Conditioned Plasma Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Autologous Conditioned Plasma Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Autologous Conditioned Plasma Therapy Market Share by Regions: 2020 VS 2027
Figure 16. Global Autologous Conditioned Plasma Therapy Market Share by Regions (2022-2027)
Figure 17. Global Autologous Conditioned Plasma Therapy Market Share by Players in 2020
Figure 18. Global Top Autologous Conditioned Plasma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Conditioned Plasma Therapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Autologous Conditioned Plasma Therapy Revenue in 2020
Figure 20. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Type (2016-2021)
Figure 21. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Type (2022-2027)
Figure 22. North America Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Autologous Conditioned Plasma Therapy Market Share by Type (2016-2027)
Figure 24. North America Autologous Conditioned Plasma Therapy Market Share by Application (2016-2027)
Figure 25. North America Autologous Conditioned Plasma Therapy Market Share by Country (2016-2027)
Figure 26. United States Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Autologous Conditioned Plasma Therapy Market Share by Type (2016-2027)
Figure 30. Europe Autologous Conditioned Plasma Therapy Market Share by Application (2016-2027)
Figure 31. Europe Autologous Conditioned Plasma Therapy Market Share by Country (2016-2027)
Figure 32. Germany Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Autologous Conditioned Plasma Therapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Autologous Conditioned Plasma Therapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Autologous Conditioned Plasma Therapy Market Share by Region (2016-2027)
Figure 42. China Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Autologous Conditioned Plasma Therapy Market Share by Type (2016-2027)
Figure 50. Latin America Autologous Conditioned Plasma Therapy Market Share by Application (2016-2027)
Figure 51. Latin America Autologous Conditioned Plasma Therapy Market Share by Country (2016-2027)
Figure 52. Mexico Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Autologous Conditioned Plasma Therapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Autologous Conditioned Plasma Therapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Autologous Conditioned Plasma Therapy Market Share by Country (2016-2027)
Figure 58. Turkey Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Autologous Conditioned Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Zimmer Biomet Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 62. Terumo Corporation Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 63. AdiStem Ltd. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 64. Arthrex, Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 65. Stryker Corporation Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 66. Cesca Therapeutics, Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 67. Biotechnology Institute BTI Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 68. Dr. PRP America LLC Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 69. EmCyte Corporation Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 70. Vivostat A/S Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 71. Regen Lab SA Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 72. Royal Biologics Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 73. Exactech, Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 74. Plateltex S.R.O. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の多血小板血漿療法市場規模・現状・予測（2021年-2027年） Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine. Market Analys…- 多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025 Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.In 2018, the g…
- 多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025 Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.In 2018, the g…
- 世界の多血小板血漿治療市場規模・現状・予測（2021年-2027年） Platelet-rich plasma (PRP) therapy uses injections of a concentration of a patient's own platelets to accelerate the healing of injured tendons, ligaments, muscles and joints. In this way, PRP injections use each individual patient's own healing system to improve musculoskeletal problems. The resear…
- 多血小板血漿（PRP）のグローバル市場2021 Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play …